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Hiccups or singulata are rhythmic involuntary movements of the diaphragm, caused by a variety of conditions that
interfere with the functions of the nerve nuclei in the medulla and supra-spinal hiccup center. Although neurotransmitters
and receptors involved in the pathophysiology of hiccups are not defined well, dopamine has been considered to
play an important role. In some cases, chlorpromazine or other antipsychotics are used for the treatment of
intractable hiccups but their efficacy is often limited. This report involves an 18-year-old patient who experienced
two episodes of intractable hiccups triggered by stress, which lasted for weeks or even months. In both episodes,
haloperidol was initially used, but there was no significant effect. In contrast, risperidone, the second-generation
antipsychotic that possesses a dopamine-serotonin antagonist property, completely abolished the hiccups 6 hours
after administration. This is one of few case reports in which two antipsychotics were challenged for a single patient
with hiccups, and the effects of the drugs were obviously different. Our finding suggests that, in addition to
dopaminergic system, the serotonergic systems may be involved in the pathophysiology of some hiccup cases and
that the serotonin-acting antipsychotics such as risperidone should be considered as a choice in the drug treatment of
intractable hiccups.
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Hiccups (singultus) are involuntary contractions of the
diaphragm that repeat several times per minutes with
“hic” sounds at the pharynx [1,2]. Hiccups are caused by
a variety of conditions that interfere with the functions
at the nerve nuclei in the medulla and/or the supra-
spinal hiccup center, which regulate the rhythmic move-
ment of the diaphragm [3,4]. It is not well defined which
kinds of neurotransmitters and receptors in these nervous
systems are involved in the pathophysiology of hiccups,
but dopamine has been considered to play a role [2,5].
Hiccups are very common physical responses and are
usually short lasting and self limiting [1,2]. However,
medical treatments are sometimes required for persistent
or intractable hiccups. Chlorpromazine and metoclopra-
mide are the most frequently used first-line treatments
[2,3]. Assuming that dopamine is involved in the patho-
physiology of hiccups, chlorpromazine and other antipsy-
chotics should provide clear outcomes in the treatment of* Correspondence: thayashi2r@gmail.com
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unless otherwise stated.hiccups [2,6]. However, these drugs do not always provide
favorable results. Furthermore, recent case reports suggest
that antipsychotics may actually trigger hiccups in some
cases [7-9]. So it seems that, so far, no pharmacotherapeu-
tic algorithm in treatment of hiccups has been established.
Here, we report a case of persistent hiccups abolished
after the administration of risperidone but not after the
administration of haloperidol.Case presentation
Our patient is an 18-year-old male. When he was 16 and
when he was busy for school activities, he suffered from
persistent and rhythmic hiccup-like breaths that often
disturbed his speech. The symptoms, however, disap-
peared in sleep. Initially, he consulted an otorhinolaryn-
gologist, but no diagnostic conclusion was made. At one
department of pediatrics of a university hospital, vocal
tic disorder was suspected and he was administered with
a daily dose of haloperidol 1.5 mg and trihexyphenidyl
4 mg. After 3 months, the symptom had spontaneously
disappeared. Thus, the contribution of haloperidol treat-
ment to the outcome was unclear.ral. This is an Open Access article distributed under the terms of the Creative
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company. After getting into that company, he attended a
trainee seminar at the age of 18, which was located far
from his hometown. There, he suffered from upper air-
way inflammation, with symptoms such as: coughs, spu-
tum, and slight fevers. He was admitted to a general
hospital for 2 days, and these symptoms disappeared.
After the discharge, however, he began to complain
about rhythmic hiccup-like breaths similar to those he
experienced while he was in high school. An internist re-
lated his involuntary movement to his previous diagno-
sis, i.e., vocal tic disorder. Antitussive drugs, haloperidol
1.5 mg and trihexyphenidyl 4 mg, were administered
again for 16 days. Since his symptoms were not respon-
sive to the medication, he consulted to our hospital.
His body temperature was normal. All laboratory data
including chest X-ray and C-reactive protein were normal.
Pharyngeal noises that sounded like “gyu, gyu” were heard
almost every second. The noises continued all day long
but disappeared while the patient was sleeping. To stop
his hiccups, he tried a variety of physical measures, such
as holding breath and drinking water while pinching the
nose. But, none of them was effective. At the medical in-
spection of his body muscle movements, we found a series
of breathing diaphragm spasms and twitching of his ab-
dominal muscles. Those movements synchronized well
with his pharyngeal noises. By gathering these laboratory
and observational data together, we concluded that he suf-
fered from hiccups but not from cough or vocal tic dis-
order. Diazepam 10 mg was intramuscularly administered,
but no apparent effect was observed. Next, we decided to
challenge an atypical antipsychotic drug. For monitoring
of the drug efficacy, we chose risperidone solution at a
relatively high dose that enables the rapid increase of the
blood concentration of the drug. In contrast to diazepam,
oral solution of risperidone 3 mg (3 ml) began to decrease
his hiccup rates 15 minutes after the administration. For
the follow-up monitoring of his hiccups, he was hospital-
ized to our hospital. Six hours after the first administra-
tion of risperidone solution, complete abolishment of his
hiccups was observed. He could talk smoothly without
any pharyngeal noises and twitches of the abdominal mus-
cles. He claimed that the symptoms observed in his two
hiccup episodes were exactly the same and that the epi-
sodes occurred when busy and stressful days continued.
Next day, he was discharged without any symptoms ob-
served. Risperidone was not re-administered. Three psychi-
atrists found no apparent signs supporting his diagnosis
of schizophrenia, depression, personality disorders, and
anxiety or somatoform disorders.
Conclusion
Cough and intense emotions such as fear and anxiety are
known to be causes of hiccups [9-11]. It is likely thatcoughs due to pre-existing colds and stresses during the
training program caused intractable hiccups in our case
that has no comorbidity of psychiatric disorders. It would
be particularly important to highlight that his hiccups dra-
matically responded to risperidone but not to haloperidol,
in spite of the fact that both are the potent inhibitors of
dopamine D2 receptors. The difference in the drug effect
could be partly due to the fact that haloperidol was
co-administered with trihexyphenidyl. Muscarinic receptor
antagonist trihexyphenidyl is known to increase the extra-
cellular dopamine and gamma-aminobutyric acid (GABA)
levels in the substantia nigra [12]. However, whether the
elevation of dopamine or GABA levels in the substantia
nigra affects involuntary movements of the diaphragm is
unknown. Another possibility explaining the effect of ris-
peridone could be the different receptor-binding profiles
of these two antipsychotics. Risperidone possesses slightly
lower or similar affinities for dopamine D1, D2, D3, and D4
receptors when compared with haloperidol [13-16]. On
the other hand, risperidone possesses a much higher affin-
ity for the serotonin 2A (5-HT2A) receptors than haloperi-
dol, thus the D2/5-HT2A affinity ratio of risperidone is
approximately 500 times higher than that of haloperidol
[13,16,17]. In addition to 5-HT2A inhibition, risperidone is
known to stimulate cortical and subcortical serotonin out-
put [18]. 5-HT is known to be involved in both the anxiety
and the neural transmission in the reflex arcs, which are
involved in the generation of hiccups [3,9]. Furthermore,
recent reports are accumulating evidence that serotoner-
gic agents may ameliorate hiccups [19,20]. These findings,
together with our case, indicate that serotonin-acting anti-
psychotics such as risperidone may be effective in the
treatment of some hiccup cases that may involve dysfunc-
tions of the serotonergic systems (e.g., hiccups related to
stress or anxiety). Furthermore, our finding may suggest
that there are subtypes of intractable hiccups and the
associated comorbidity/etiology may underlie different
sensitivity to a specific category of antipsychotic drugs.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.
Competing interests
All authors declare that they have no competing interests.
Authors’ contributions
All three authors were directly involved in the treatment of the case. TN has
made substantial contributions to design of the treatment paradigm. TH has
made major contributions to interpretation of the treatment outcome and
drafting of the manuscript. All three authors have given final approval of the
version to be published and agree to be accountable for all aspects of the
work in ensuring that questions related to the accuracy or integrity of any
part of the work are appropriately investigated and resolved. All authors read
and approved the final manuscript.
Nishikawa et al. Annals of General Psychiatry  (2015) 14:13 Page 3 of 3Acknowledgements
We appreciate the patient and his family agreeing with the participation to
our treatment program.
Received: 21 November 2014 Accepted: 18 February 2015
References
1. Rizzo C, Vitale C, Montagnini M. Management of intractable hiccups: an
illustrative case and review. Am J Hosp Palliat Care. 2014;31(2):220–4.
2. Friedman NL. Hiccups: a treatment review. Pharmacotherapy. 1996;16(6):986–95.
3. Lewis JH. Hiccups: causes and cures. J Clin Gastroenterol. 1985;7(6):539–52.
4. Thaci B, Burns JD, Delalle I, Vu T, Davies KG. Intractable hiccups resolved
after resection of a cavernous malformation of the medulla oblongata. Clin
Neurol Neurosurg. 2013;115(10):2247–50.
5. Stegmeier-Petroianu A, Petroianu GA. Hiccups and dopamine. Am J Health
Syst Pharm. 2008;65(22):2092–4.
6. Alderfer BS, Arciniegas DB. Treatment of intractable hiccups with olanzapine
following recent severe traumatic brain injury. J Neuropsychiatry Clin
Neurosci. 2006;18(4):551–2.
7. Silverman MA, Leung JG, Schak KM. Aripiprazole-associated hiccups: case
and closer look at the association between hiccups and antipsychotics.
J Pharm Pract. 2014;27(6):587–90.
8. Yeh YW. Persistent hiccups associated with switching from risperidone to
aripiprazole in a schizophrenic patient with cerebral palsy. Clin
Neuropharmacol. 2011;34(4):135–6.
9. Miyaoka H, Kamijima K. Perphenazine-induced hiccups. Pharmacopsychiatry.
1999;32(2):81.
10. Theohar C, McKegney FP. Hiccups of psychogenic origin: a case report and
review of the literature. Compr Psychiatry. 1970;11(4):377–84.
11. Hassen GW, Singh MM, Kalantari H, Yemane-Merriwether S, Ferrante S, Shaw
R. Persistent hiccups as a rare presenting symptom of pulmonary embolism.
West J Emerg Med. 2012;13(6):479–83.
12. Izurieta-Sanchez P, Sarre S, Ebinger G, Michotte Y. Muscarinic antagonists in
substantia nigra influence the decarboxylation of L-dopa in striatum. Eur J
Pharmacol. 2000;399(2–3):151–60.
13. Blin O. A comparative review of new antipsychotics. Can J Psychiatry.
1999;44(3):235–44.
14. Floresca CZ, Schetz JA. Dopamine receptor microdomains involved in
molecular recognition and the regulation of drug affinity and function.
J Recept Signal Transduct Res. 2004;24(3):207–39.
15. Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor
explain the action of atypical antipsychotics?: A new hypothesis. Am J
Psychiatry. 2001;158(3):360–9.
16. Leysen JE, Janssen PM, Megens AA, Schotte A. Risperidone: a novel
antipsychotic with balanced serotonin-dopamine antagonism, receptor
occupancy profile, and pharmacologic activity. J Clin Psychiatry.
1994;55(Suppl):5–12.
17. Reimold M, Solbach C, Noda S, Schaefer JE, Bartels M, Beneke M, et al.
Occupancy of dopamine D(1), D(2) and serotonin (2A) receptors in
schizophrenic patients treated with flupentixol in comparison with
risperidone and haloperidol. Psychopharmacology (Berl). 2007;190(2):241–9.
18. Amato D. Serotonin in antipsychotic drugs action. Behav Brain Res.
2015;277:125–35.
19. Vaidya V. Sertraline in the treatment of hiccups. Psychosomatics.
2000;41(4):353–5.
20. Takahashi T, Murata T, Omori M, Tagaya M, Wada Y. Successful treatment of
intractable hiccups with serotonin (5-HT)1A receptor agonist. J Neurol.
2004;251(4):486–7. Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
